{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:38:11Z","timestamp":1777631891251,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12874-017-0367-8","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T08:29:44Z","timestamp":1499675384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-6557","authenticated-orcid":false,"given":"Charlotte A.","family":"Bolch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Jarosek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Virnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"367_CR1","unstructured":"American Cancer Society, Inc. What are the key statistics about prostate cancer? \nhttp:\/\/www.cancer.org\/cancer\/prostatecancer\/detailedguide\/prostate-cancer-key-statistics\n\n. Revised March 12, 2015. Accessed 14 Mar 2015."},{"key":"367_CR2","unstructured":"National Cancer Institute, National Institutes of Health. SEER Stat Fact Sheets: Prostate Cancer. Bethesda, MD: National Cancer Institute. \nhttp:\/\/seer.cancer.gov\/statfacts\/html\/prost.html\n\n. Published April 2015. Accessed 14 Mar 2015."},{"issue":"5","key":"367_CR3","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0022-5347(01)64145-4","volume":"158","author":"MW Plawker","year":"1997","unstructured":"Plawker MW, Fleisher JM, Vapnek EM, et al. Current trends in prostate cancer diagnosis and staging among United States urologists. J Urol. 1997;158(5):1853\u20138.","journal-title":"J Urol"},{"issue":"5","key":"367_CR4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0022-5347(01)67463-9","volume":"153","author":"DG McLeod","year":"1995","unstructured":"McLeod DG. Editorial: Prostate cancer diagnosis. J Urol. 1995;153(5):1570\u20131.","journal-title":"J Urol"},{"issue":"1","key":"367_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.juro.2013.01.103","volume":"190","author":"JE Bekelman","year":"2013","unstructured":"Bekelman JE, Suneja G, Guzzo T, et al. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns. J Urol. 2013;190(1):97\u2013101.","journal-title":"J Urol"},{"issue":"2","key":"367_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.eururo.2014.08.061","volume":"67","author":"SL Jarosek","year":"2015","unstructured":"Jarosek SL, Virnig BA, Chu H, et al. Propensity- weighted long- term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol. 2015;67(2):273\u201380. doi:\n10.1016\/j.eururo.2014.08.061\n\n.","journal-title":"Eur Urol"},{"issue":"24","key":"367_CR7","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1200\/JCO.2007.12.9866","volume":"26","author":"JJ Dignam","year":"2008","unstructured":"Dignam JJ, Kocherginsky MN. Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol. 2008;26(24):4027\u201334.","journal-title":"J Clin Oncol"},{"issue":"6","key":"367_CR8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"T Gooley","year":"1999","unstructured":"Gooley T, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695\u2013706.","journal-title":"Stat Med"},{"issue":"8","key":"367_CR9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/sim.4780120803","volume":"12","author":"M Pepe","year":"1993","unstructured":"Pepe M, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data. Stat Med. 1993;12(8):737\u201351.","journal-title":"Stat Med"},{"issue":"1","key":"367_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10985-009-9130-8","volume":"16","author":"M Bekaert","year":"2010","unstructured":"Bekaert M, Vansteelandt S, Mertens K. Adjusting for time-varying confounding in the subdistribution analysis of a competing risk. Lifetime Data Anal. 2010;16(1):45\u201370.","journal-title":"Lifetime Data Anal"},{"issue":"4","key":"367_CR11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/aje\/kwu122","volume":"181","author":"SR Cole","year":"2015","unstructured":"Cole SR, Lau B, Eron JJ, et al. Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol. 2015;181(4):238\u201345.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"367_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41\u201355.","journal-title":"Biometrika"},{"issue":"5","key":"367_CR13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hern\u00e1n MA, Brumback B. Marginal structural models and causal inference in Epidemiology. Epidemiology. 2000;11(5):550\u201360.","journal-title":"Epidemiology"},{"issue":"5","key":"367_CR14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/cncr.26402","volume":"118","author":"K Chamie","year":"2012","unstructured":"Chamie K, Saigal CS, Lai J, et al. Quality of care in patients with bladder cancer. Cancer. 2012;118(5):1412\u201321.","journal-title":"Cancer"},{"issue":"1","key":"367_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/biostatistics\/2.1.85","volume":"2","author":"JP Fine","year":"2001","unstructured":"Fine JP. Regression modeling of competing crude failure probabilities. Biostatistics. 2001;2(1):85\u201397.","journal-title":"Biostatistics"},{"issue":"2","key":"367_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","volume":"170","author":"B Lau","year":"2009","unstructured":"Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244\u201356.","journal-title":"Am J Epidemiol"},{"issue":"16","key":"367_CR17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L, et al. Twenty- year follow- up of a randomized study comparing breast- conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227\u201332.","journal-title":"N Engl J Med"},{"issue":"11","key":"367_CR18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jama.280.11.975","volume":"280","author":"PC Albertsen","year":"1998","unstructured":"Albertsen PC, Hanley J, Gleason D, et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA. 1998;280(11):975\u201380.","journal-title":"JAMA"},{"issue":"3","key":"367_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2188\/jea.JE20140118","volume":"25","author":"E Rodriguez-Camacho","year":"2015","unstructured":"Rodriguez-Camacho E, Pita-Fernandez S, Pertega-Diaz S, et al. Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis. J Epidemiol. 2015;25(3):231\u20138.","journal-title":"J Epidemiol"},{"issue":"1","key":"367_CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.0006-341X.2005.031209.x","volume":"61","author":"JP Klein","year":"2005","unstructured":"Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics. 2005;61(1):223\u20139.","journal-title":"Biometrics"},{"issue":"1","key":"367_CR21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","volume":"13","author":"HT Kim","year":"2007","unstructured":"Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res. 2007;13(1):559\u201365.","journal-title":"Clin Cancer Res"},{"issue":"446","key":"367_CR22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94(446):496\u2013509.","journal-title":"JASA"},{"issue":"1","key":"367_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","volume":"75","author":"SR Cole","year":"2004","unstructured":"Cole SR, Hern\u00e1n MA. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004;75(1):45\u20139.","journal-title":"Comput Methods Prog Biomed"},{"key":"367_CR24","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Statist Med. 2007;26:2389\u2013430. doi:\n10.1002\/sim.2712\n\n.","journal-title":"Statist Med"},{"issue":"7","key":"367_CR25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jech.2004.029496","volume":"60","author":"MA Hern\u00e1n","year":"2006","unstructured":"Hern\u00e1n MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006;60(7):578\u201386.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"367_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/aje\/kwq084","volume":"172","author":"SR Cole","year":"2010","unstructured":"Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations. Am J Epidemiol. 2010;172(1):107\u201315.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"367_CR27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"SR Cole","year":"2008","unstructured":"Cole SR, Hern\u00e1n MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656\u201364.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"367_CR28","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/MLR.0b013e3181d99107","volume":"48","author":"R Varadhan","year":"2010","unstructured":"Varadhan R, Weiss CO, Segal J, et al. Evaluating health outcomes in the presence of competing risks a review of statistical methods and clinical applications. Med Care. 2010;48(6):S96\u2013S105.","journal-title":"Med Care"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-017-0367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T08:29:58Z","timestamp":1499675398000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-017-0367-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1186\/s12874-017-0367-8","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]},"article-number":"93"}}